News

North Chicago, Illinois-based AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. With ...
We recently published a list of Did Jim Cramer Nail or Miss These 11 Stock Predictions? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Jim Cramer has been buzzing about UnitedHealth Group, the largest U.S. health insurer, especially after its brutal 41% stock ...
Jim Cramer recently gave Eli Lilly a thumbs-up, noting it’s a great time to buy because the stock has dropped significantly.
Jim Cramer continues his enthusiastic endorsement of Broadcom, calling it a top position in his Charitable Trust. He ...
Jim Cramer, the always-colorful market commentator, gave Stryker Corporation a lukewarm thumbs-up on his radar of 21 stocks.
Jim Cramer recently weighed in on Palantir, calling it expensive but admitting it outpaces others in growth and margins.
We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at ...
Lending support to his choice, Rocket Companies, on May 8, posted better-than-expected quarterly sales. Markets expect rate ...
CNBC’s Jim Cramer on Friday detailed how President Donald Trump’s global trade decisions seriously inhibit two of the U.S.’s biggest tech titans.
Eli Lilly, Navitas, Red Cat, Mr. Cooper, Rocket, Liberty Energy, Rio Tinto, and DeFi Development. Russia Calls Trump ...